Circular Genomics secures $15 million in Series A funding led by Mountain Group Partners to enhance early detection tools for Alzheimer's disease.
Amount Raised
$15 Million
Round Type
Series A
AlbuquerqueBiotechnologyInvestors
Description
Circular Genomics has closed a $15 million Series A financing round, aimed at advancing its circular RNA platform for Alzheimer's detection. Led by Mountain Group Partners, the funding will expedite clinical development and commercialization efforts. Supported by key investors, this capital will be utilized for clinical validation and platform innovation. The initiative seeks to reshape the standard of care for neurological disorders.
Quick answer
Circular Genomics raised $15 Million in a Series A round, dated December 1, 2025. Investors: Poplar Grove Investors, Hip Fund, Alzheimer’s Drug Discovery Foundation and Mountain Group Partners. Circular Genomics is based in Albuquerque, New Mexico, United States.
- How much did Circular Genomics raise?
- Circular Genomics raised $15 Million in a Series A round on December 1, 2025.
- Who invested in Circular Genomics?
- Poplar Grove Investors, Hip Fund, Alzheimer’s Drug Discovery Foundation and Mountain Group Partners are named as investors in this round.
- What does Circular Genomics do?
- Circular Genomics is the global leader in the use of circular RNA as a novel biomarker to power precision medicine to improve the diagnosis and treatment of neurological and psychiatric conditions.
- Where is Circular Genomics based and how big is it?
- Circular Genomics is based in Albuquerque, New Mexico, United States.
- Who are the decision-makers at Circular Genomics?
- Fundz holds 3 contacts at Circular Genomics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as Circular Genomics that raised within 45 days of this round, from Fundz verified event records.
- CRB raised $50M on January 15, 2026.
- Transition Metal Solutions raised $6M (Seed) on January 15, 2026.
- SenseUP raised $3.5M (Seed) on January 15, 2026.
- Cantai Therapeutics raised $3M (Seed) on January 15, 2026.
- Science&Humans raised $7.9M (Series A) on January 15, 2026.
- MARS Bioimaging raised $15M (Series A) on January 14, 2026.
Who to call at Circular Genomics, and when
A new round usually means Circular Genomics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Circular Genomics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Circular Genomics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Circular Genomics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Circular Genomics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansCircular Genomics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.